Akili Inc Valuation
| AKLIDelisted Stock | USD 0.43 0.00 0.00% |
Akili is overvalued. Akili Inc shows a prevailing Real Value of $0.32 per share. The current price of the firm is $0.43. Our model approximates the value of Akili Inc from analyzing the firm fundamentals such as Return On Equity of -0.68, operating margin of (28.37) %, and Shares Outstanding of 78.73 M as well as examining its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that Akili's price fluctuation is very steady at this time. Calculation of the real value of Akili Inc is based on 3 months time horizon. Increasing Akili's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since Akili is currently traded on the exchange, buyers and sellers on that exchange determine the market value of Akili Stock. However, Akili's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.43 | Real 0.32 | Hype 0.43 |
The intrinsic value of Akili's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence Akili's stock price.
Estimating the potential upside or downside of Akili Inc helps investors to forecast how Akili stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Akili more accurately as focusing exclusively on Akili's fundamentals will not take into account other important factors: Akili Total Value Analysis
Akili Inc is presently expected to have valuation of (15.56 M) with market capitalization of 34.1 M, debt of 15.48 M, and cash on hands of 45.62 M. The negative valuation of Akili may imply that the market is not capable to price the future growth of the company or it is pricing it at zero value. It may also suggest that takeover valuation may not have captured all of the outstanding financial obligations of the company both on and off balance sheet. Investors should vigilantly validate all of the Akili fundamentals.| Takeover Price | Market Cap | Debt Obligations | Cash |
(15.56 M) | 34.1 M | 15.48 M | 45.62 M |
Akili Investor Information
About 23.0% of the company shares are held by company insiders. The company has price-to-book (P/B) ratio of 0.35. Some equities with similar Price to Book (P/B) outperform the market in the long run. Akili Inc recorded a loss per share of 0.61. The entity had not issued any dividends in recent years. Based on the key indicators obtained from Akili's historical financial statements, Akili Inc is not in a good financial situation at the moment. It has a very high risk of going through financial straits in December.Akili Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Akili has an asset utilization ratio of 2.09 percent. This signifies that the Company is making $0.0209 for each dollar of assets. An increasing asset utilization means that Akili Inc is more efficient with each dollar of assets it utilizes for everyday operations.Akili Ownership Allocation
Akili holds a total of 78.73 Million outstanding shares. Over half of Akili's outstanding shares are owned by other corporate entities. These other corporate entities are typically referred to as corporate investors that acquire positions in a given instrument to benefit from reduced trade commissions. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.Akili Profitability Analysis
The company reported the previous year's revenue of 1.68 M. Net Loss for the year was (59.49 M) with loss before overhead, payroll, taxes, and interest of (118 K).About Akili Valuation
An absolute valuation paradigm, as applied to Akili Stock, attempts to find the value of Akili Inc based on its fundamental and basic technical indicators. By analyzing Akili's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of Akili's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of Akili. We calculate exposure to Akili's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Akili's related companies.Akili, Inc., a digital medicine company, develops digital therapeutics for cognitive impairments. It provides EndeavorRx, a physician-prescribed video game-based treatment designed to directly target cognitive functioning. Akili operates under Health Information Services classification in the United States and is traded on NASDAQ Exchange. It employs 127 people.
Akili Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 78.2 M |
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.
Other Consideration for investing in Akili Stock
If you are still planning to invest in Akili Inc check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Akili's history and understand the potential risks before investing.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges |